or Try an Advanced Search...

    Technical Analysis for DNLI - Denali Therapeutics Inc.

    Grade Last Price % Change Price Change
    D 24.69 1.94% 0.47
    DNLI closed up 1.94 percent on Friday, November 22, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    4 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Down
    Historical DNLI trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish 1.94%
    Wide Bands Range Expansion 1.94%
    Oversold Stochastic Weakness 1.94%
    Slingshot Bearish Bearish Swing Setup 1.11%
    Wide Bands Range Expansion 1.11%
    Oversold Stochastic Weakness 1.11%
    Older End-of-Day Signals for DNLI ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 13 hours ago
    Possible Inside Day about 13 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    Up 1% about 17 hours ago
    Down 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DNLI Chart by TradingView
    Basic chart:

    Profile

    Denali Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing therapeutics for neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Organ Systems Neuroscience Alzheimer's Disease Parkinson's Disease Neurological Disorders Neurodegenerative Diseases Amyotrophic Lateral Sclerosis Degenerative Disease Neurodegeneration Senescence

    Is DNLI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 16 Denali Has A Neurodegenerative Edge Despite Market Skepticism
    Nov 15 We're Hopeful That Denali Therapeutics (NASDAQ:DNLI) Will Use Its Cash Wisely
    Nov 8 Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging
    Nov 7 Denali Therapeutics GAAP EPS of -$0.63
    Nov 6 Denali Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
    Oct 30 Analysts Estimate Arcus Biosciences, Inc. (RCUS) to Report a Decline in Earnings: What to Look Out for
    Oct 29 Denali Therapeutics Inc. (DNLI) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
    Oct 13 Denali Therapeutics Inc. (DNLI): Jeff Bezos Is Buying This Stock Now
    Oct 11 Sanofi, Denali face another mid-stage setback for neurology therapy
    Oct 7 Strength Seen in Voyager Therapeutics (VYGR): Can Its 17.5% Jump Turn into More Strength?
    See more DNLI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 33.33
    52 Week Low 14.56
    Average Volume 837,506
    200-Day Moving Average 22.62
    50-Day Moving Average 27.88
    20-Day Moving Average 27.35
    10-Day Moving Average 26.65
    Average True Range 1.41
    RSI (14) 39.02
    ADX 19.38
    +DI 21.21
    -DI 34.18
    Chandelier Exit (Long, 3 ATRs) 29.11
    Chandelier Exit (Short, 3 ATRs) 27.75
    Upper Bollinger Bands 32.02
    Lower Bollinger Band 22.68
    Percent B (%b) 0.22
    BandWidth 34.16
    MACD Line -0.77
    MACD Signal Line -0.22
    MACD Histogram -0.5447
    Fundamentals Value
    Market Cap 3.41 Billion
    Num Shares 138 Million
    EPS -0.94
    Price-to-Earnings (P/E) Ratio -26.27
    Price-to-Sales 7.32
    Price-to-Book 2.23
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 25.83
    Resistance 3 (R3) 25.72 25.22 25.64
    Resistance 2 (R2) 25.22 24.93 25.28 25.58
    Resistance 1 (R1) 24.96 24.75 25.09 25.07 25.51
    Pivot Point 24.46 24.46 24.53 24.52 24.46
    Support 1 (S1) 24.20 24.17 24.33 24.31 23.87
    Support 2 (S2) 23.70 23.99 23.76 23.80
    Support 3 (S3) 23.44 23.70 23.74
    Support 4 (S4) 23.55